Browse Related Topics For:

Patents

3321
Patent Litigation
2605
Patent Infringement
1309
USPTO
1199
Patent Trial and Appeal Board
1150
Inter Partes Review (IPR) Proceeding
1088
Patent-Eligible Subject Matter
992
SCOTUS
860
Pharmaceutical Industry
749
Pharmaceutical Patents
627
Claim Construction
610
America Invents Act
610
Appeals
544
Patent Applications
539
Prior Art
517
CLS Bank v Alice Corp
490
Popular
371
Obviousness
361
Patent Reform
332
Infringement
314
Section 101
310
Patent Invalidity
298
Generic Drugs
288
Covered Business Method Patents
282
Trademarks
269
Software
266
Abstract Ideas
262
Biotechnology
260
ANDA
251
Copyright
251
FDA
248
Post-Grant Review
244
Prescription Drugs
232
Mayo v. Prometheus
226
EU
223
Patent Trolls
222
Intellectual Property Protection
221
DNA
221
Myriad
218
ITC
210
Design Patent
210
Induced Infringement
184
Trade Secrets
182
Patent-in-Suit
177
Biosimilars
174
Hatch-Waxman
173
AMP v Myriad
170
Covered Business Method Proceedings
166
Corporate Counsel
163
FTC
159
Patent Ownership
158
Summary Judgment
157
Attorney's Fees
154
BPCIA
154
Inventors
151
Computer-Related Inventions
148
Apple
143
Australia
140
Discovery
137
Life Sciences
133
Human Genes
133
Young Lawyers
130
Technology
124
Octane Fitness v. ICON
119
Standard Essential Patents
118
IP License
118
Reversal
117
Indefiniteness
117
Willful Infringement
116
Inventions
113
En Banc Review
112
Damages
111
License Agreements
108
Medical Devices
108
Patent Royalties
107
Evidence
102
First-to-File
102
Motion to Dismiss
102
Software Patents
101
Standing
100
Amgen
99
Jurisdiction
99
Standard of Review
98
Alice Corporation
96
Intellectual Property Litigation
94
FRAND
93
Royalties
93
Sandoz
92
CLS Bank
92
Expert Testimony
92
Teva Pharmaceuticals
89
Broadest Reasonable Interpretation Standard
89
Declaratory Judgments
89
Genetic Materials
88
Non-Practicing Entities
88
Samsung
86
Preliminary Injunctions
85
Federal Rules of Civil Procedure
85
Motion to Amend
85
Nautilus Inc. v. Biosig Instruments
83
China
83
Patent Term Adjustment
83
Teva v Sandoz
82
Direct Infringement
82
Manufacturers
82
Patent Prosecution
81
Sandoz v Amgen
78
Apple v Samsung
77
Estoppel
77
Section 337
74
Actavis Inc.
74
De Novo Standard of Review
74
Halo v Pulse
74
Microsoft
72
Biologics
72
Google
72
Licenses
72
UK
71
Enhanced Damages
71
Utility Patents
69
Apotex
69
Myriad-Mayo
66
Limelight v Akamai
66
Remand
65
Reverse Payment Settlement Agreements
64
Innovation Act
64
Patent Exhaustion
63
Cisco v CommilUSA
63
Motion To Stay
62
Clear Error Standard
61
FTC v Actavis
61
Highmark v. Allcare
60
Akamai Technologies
60
Petition For Rehearing
59
Antitrust Litigation
58
Healthcare
57
Good Faith
57
Novartis
56
Certiorari
56
European Patent Office
56
Joinder
55
Injunctions
55
Laches
55
Patent Dance
55
Patent Filings
54
Administrative Proceedings
54
First-to-Invent
54
Proposed Legislation
53
Kimble v Marvel Enterprises
53
Personal Jurisdiction
52
Canada
52
Mylan Pharmaceuticals
52
Product of Nature Doctrine
52
Sequenom
51
Expert Witness
51
Imports
50
Burden of Proof
50
DOJ
50
Innovation
50
Medtronic
50
Real Party in Interest
50
Unified Patent Court
49
Copyright Infringement
49
Markman Hearing
49
Misappropriation
48
Exceptional Case
48
Patent Examinations
48
Pay-For-Delay
48
Startups
47
Judicial Review
47
Settlement
47
Vacated
46
Limelight Networks
46
Smartphones
46
Unitary Patent
45
Cisco
45
Dismissals
45
Preemption
44
Inter Partes Reexamination
44
Patent Assertion Entities
44
Written Descriptions
43
35 U.S.C. § 284
43
AstraZeneca
43
CAFC
43
EPO
43
Ex Partes Reexamination
43
Motorola
43
Preponderance of the Evidence
42
Cuozzo Speed Technologies
42
Notice Requirements
42
Patent Validity
42
Risk Mitigation
41
Administrative Procedure Act
41
Bilski
41
Confidential Information
41
Guidance Update
41
Noninfringement
41
Patent Cooperation Treaty
41
Statute of Limitations
40
Breach of Contract
40
Pfizer
40
Request for Continued Examination
40
Sanctions
39
BRCA
39
European Court of Justice (ECJ)
38
Class Action
38
Means-Plus-Function
38
On-Sale Bar
38
Patent Portfolios
38
Pleading Standards
38
UK Brexit
37
Brulotte
37
Commercial Marketing
37
Depositions
37
Petition for Writ of Certiorari
37
Stare Decisis
37
The Patent Act
36
Competition
36
Component Parts Doctrine
36
Eli Lilly
36
Genetically Engineered Seed
36
Seagate
36
Sherman Act
35
Arbitration
35
Inequitable Conduct
35
Pleadings
35
Public Comment
35
USPTO Pilot Program
34
Abuse of Discretion
34
Cuozzo Speed Technologies v Lee
34
Lanham Act
34
Software Developers
34
Universities
33
Abuse of Process
33
Article III
33
Disclosure Requirements
33
FDA Approval
33
Final Judgment
33
Validity
33
Venue
33
Watson Pharmaceuticals
32
ALJ
32
Diagnostic Method
32
Divided Infringement
32
Method Claims
32
Monsanto
31
Attorney-Client Privilege
31
Bad Faith
31
Extraterritoriality Rules
31
Indirect Infringement
31
Merck
31
Safe Harbors
30
Japan
30
Judicial Discretion
30
Life Technologies v Promega
30
Trademark Registration
29
Advertising
29
Bowman v Monsanto
29
Enfish v Microsoft
29
Hart-Scott-Rodino Act
29
Honest Belief Defense
29
PATENT Act
29
Stem cells
28
Automotive Industry
28
Doctrine of Equivalents
28
Fee-Shifting
28
Genetic Testing
28
Hague Agreement
28
Injunctive Relief
28
Kappos
28
Mobile Devices
28
Petrella v. MGM
28
Stryker v Zimmer
28
Subject Matter Jurisdiction
28
WIPO
27
Chevron Deference
27
Hospira
27
Legislative Agendas
27
Limelight
27
Patent Terms
27
Technology Sector
26
Examiners
26
Jury Verdicts
26
Oral Argument
26
Pending Legislation
26
The Copyright Act
25
Allergan Inc
25
Amicus Briefs
25
Counterclaims
25
Exports
25
First Amendment
25
Foreign Patent Applications
25
Gene Patenting
25
Genentech
25
Internet
25
Litigation Strategies
25
Orange Book
25
Ultramercial v Hulu
24
Antitrust Provisions
24
Australian Patent Office
24
Cell Phones
24
Enforcement
24
Frivolous Lawsuits
24
Standard of Proof
24
Suprema
24
Trade Dress
24
Unfair Competition
23
ACLU
23
Calculation of Damages
23
Collateral Estoppel
23
Hedge Funds
23
Patent Prosecution Highway
23
Permanent Injunctions
23
Rule 11
23
Trademark Infringement
22
3D Printing
22
Brooks Furniture
22
Data Protection
22
First Sale Doctrine
22
Gilead Sciences
22
IP Assignment Agreements
22
Motion for Summary Judgment
22
New Legislation
22
Non-Appealable Decisions
22
Patent Owner Preliminary Response
22
Stays
21
European Commission
21
Functionality
21
Motion To Strike
21
Patent Expiration
21
RAND
21
Reissue Patents
21
Research and Development
20
Acquisitions
20
Barack Obama
20
Comment Period
20
Defend Trade Secrets Act (DTSA)
20
Filing Deadlines
20
Foreign Investment
20
Germany
20
Industrial Design
20
Judgment on the Pleadings
20
Licensing Rules
20
Proposed Amendments
20
Twombly/Iqbal Pleading Standard
19
Anti-Competitive
19
Antitrust Violations
19
Bayer
19
Cybersecurity
19
Diagnostic Tests
19
European Patent Convention
19
GlaxoSmithKline
19
Interim Guidance
19
iPhone
19
JMOL
19
Joint Infringement
19
Mootness
19
Oil & Gas
19
Personalized Medicine
19
Provisional Applications
19
Qualcomm
19
SCA Hygiene Products Aktiebolag v First Quality Baby Products
19
Trans-Pacific Partnership
18
aBLA
18
Attorney Malpractice
18
Bascom Global v AT&T Mobility
18
Biologics Price Competition and Innovation Act of 2009
18
Business Assets
18
Cancer
18
Definiteness
18
Disparagement
18
Due Process
18
Federal Register
18
Interference Proceeding
18
Issue Preclusion
18
Kirtsaeng v. John Wiley & Sons
18
New Guidance
18
Non-Disclosure Agreement
18
Protective Orders
18
Referendums
18
SEC
18
Transfer of Venue
17
Contract Term
17
Cross-Border Transactions
17
Derivation Proceeding
17
Enablement Inquiries
17
Exclusion Orders
17
Fashion Industry
17
Forum Shopping
17
Member State
17
Monopolization
17
Motion to Compel
17
Par Pharmaceutical
17
Seeds
17
Tariff Act of 1930
17
Telecommunications
17
TRIPS Agreement
17
Websites
16
Ambry
16
Ariosa
16
Bayh-Dole Act
16
Bristol-Myers Squibb
16
Clean Tech
16
Disclosure
16
Document Productions
16
Due Diligence
16
Entrepreneurs
16
Equitable Estoppel
16
Facebook
16
Forum Selection
16
Judgment As A Matter Of Law
16
Medtronic v Boston Scientific
16
Prevailing Party
16
Sprint
16
Takeda Pharmaceuticals
16
Testimony
16
Trademark Litigation
15
AbbVie
15
Additional Discovery
15
Amazon
15
Auto Manufacturers
15
Brand
15
Commercial Bankruptcy
15
Contributory Infringement
15
Declaration
15
Defense Strategies
15
Federal Rule 12(b)(6)
15
Ford Motor
15
Jury Trial
15
Lexmark
15
Marketing
15
Myriad v Ambry
15
New Zealand
15
Nintendo
15
Settlement Agreements
15
TC Heartland LLC v Kraft Foods
15
Treble Damages
15
Unfair or Deceptive Trade Practices
15
Uniform Commercial Code (UCC)
15
Venture Capital
15
WTO
14
Allergan v Sandoz
14
Customs
14
Dispute Resolution
14
DMCA
14
eBay
14
Endo Pharmaceuticals
14
Enforcement Actions
14
False Advertising
14
Foreign Corporations
14
Generic
14
International Arbitration
14
Legal Perspectives
14
Mergers
14
Plant Patents
14
PTO
14
Small Business
14
The Patent Box
14
Trademark Trial and Appeal Board
14
Uniform Trade Secrets Acts
13
Abuse of Dominance
13
Ambiguous
13
Animation
13
Assignment of Inventions
13
Cephalon
13
Confidentiality Agreements
13
Counterfeiting
13
Cross Examination
13
Cross-Border
13
Energy Sector
13
Fees
13
Final Rules
13
Innovation Patent
13
Interlocutory Appeals
13
Investors
13
Irreparable Harm
13
LG Electronics
13
Likelihood of Confusion
13
Micro Entity Status
13
Nanotechnology
13
Prior User
13
Proposed Regulation
13
Roxane Laboratories
13
Scope of the Claim
13
Section 271
13
Social Media
13
STRONG Patents Act
13
Third-Party
13
Wireless Technology
12
AFCP
12
Article of Manufacture
12
AT&T Mobility
12
Corporate Taxes
12
Daubert Standards
12
Divisional Applications
12
Domestic Industry Requirement
12
Fast Track Process
12
Federal Pilot Programs
12
Filing Fees
12
Free Speech
12
IEEE
12
Inventive Concept Test
12
Investigations
12
Miniauction
12
Mobile Apps
12
Nokia
12
Order to Stay
12
Patent Agent Privilege
12
Patent Fees
12
Patent Oppositions
12
Reaffirmation
12
SSO
12
Sua Sponte
12
Supplemental Examination
12
Suppliers
12
Writ of Mandamus
11
Anticipation
11
Assignments
11
Biopharmaceutical
11
Chemicals
11
Compliance
11
Covenant Not to Sue
11
Dell
11
Demand Letter
11
E-Commerce
11
Electronics
11
Employment Contract
11
Expiration Date
11
Extrinsic Evidence
11
Farms
11
Federal Jurisdiction
11
Fraud
11
Garmin International
11
General Electric
11
Gunn v Minton
11
Italy
11
Janssen Pharmaceuticals
11
Legislative Committees
11
Litigation Fees & Costs
11
Manufacturer Liability
11
Marvel Comics
11
Motions in Limine
11
Patent Amendments
11
Patentability Search
11
Petitions for Review
11
Pre-GATT
11
Priority Patent Claims
11
Public Disclosure
11
Public Interest
11
Public Use
11
Remedies
11
Res Judicata
11
Right of Publicity
11
SAP America Inc.
11
Sovereign Immunity
11
Substantial Evidence Standard
11
Supplemental Evidence
11
Versata
11
Video Games
10
Antitrust Investigations
10
Applications
10
Assignor Estoppel
10
Burden-Shifting
10
Claim Preclusion
10
Double Patent
10
Eleventh Amendment
10
Ex Parte
10
Failure To State A Claim
10
Fair Use
10
Fashion Design
10
FDCA
10
Fresenius
10
Highmark
10
Holidays
10
Injury-in-Fact
10
International Litigation
10
IPO
10
Licensing Rights
10
Lost Profits
10
Mediation
10
Medical Research
10
Motion for Reconsideration
10
Physicians
10
Privity of Contract
10
Profits
10
Registration
10
Reviewability Determinations
10
Rulemaking Process
10
Symantec
10
Totality of Circumstances Test
10
Transparency
10
Trump Administration
10
Webinars
10
Work Product Privilege
9
Affirmative Defenses
9
Affordable Care Act
9
Algorithms
9
Amended Complaints
9
Anti-Dumping Duty
9
Arbitration Agreements
9
Barnes and Noble
9
Burden of Production
9
Case Consolidation
9
Cease and Desist
9
Cease and Desist Orders
9
Cloud Computing
9
Customs and Border Protection
9
Data Collection
9
Domain Names
9
Duty of Candor
9
Electronic Data Transmissions
9
Exclusive Licenses
9
FCPA
9
Federal Contractors
9
Foreign Jurisdictions
9
Hana Financial v Hana Bank
9
IBM
9
Indemnification
9
Information Disclosure Statement
9
Joint Venture
9
JPO
9
Jury Awards
9
Motion for Judgment
9
Motion for Sanctions
9
MPEP
9
New Trial
9
Oracle
9
Patent Law Treaty
9
PHRMA
9
Presumption of Validity
9
Price-Fixing
9
Principal Place of Business
9
Reversible Error
9
RICO
9
Rule-of-Reason Analysis
9
Salesforce
9
Split of Authority
9
Subsidiaries
9
Supplementary Protection Certificate
9
Terminal Disclaimer
9
Trade Agreements
9
Transfers
9
Twitter
9
USTR
8
Abbott Laboratories
8
Adobe
8
Anti-Monopoly
8
Apportionment
8
Asset Seizure
8
B&B Hardware v Hargis Industries
8
Burden of Persuasion
8
Cartels
8
Classen Immunotherapies
8
Clinical Trials
8
Community Designs
8
Constitutional Challenges
8
Contract Terms
8
CRISPR
8
Cross-Licensing Agreement
8
Cybor Corp v FAS Technologies
8
DaimlerChrysler v Bauman
8
Dow Chemical
8
Draft Guidance
8
Ericsson
8
Exclusions
8
False Claims Act (FCA)
8
Filing Requirements
8
Food Manufacturers
8
Form 18
8
GMO
8
gTLD
8
Hewlett-Packard
8
Hospitals
8
HTC
8
Inherency
8
Intel
8
JPMorgan Chase
8
Misrepresentation
8
Motion to Exclude
8
Motion to Transfer
8
Music
8
OECD
8
OTDP
8
Premerger Notifications
8
Printed Publications
8
Private Right of Action
8
Product Exclusivity
8
Prometheus
8
Retailers
8
Sanofi-Aventis
8
SIPO
8
Solicitor General
8
Supply Chain
8
Tacking
8
Theft
8
Tortious Interference
8
Toshiba
8
Toyota
8
UTSA
8
Walker Process Claims
8
Wearable Technology
8
Wyeth
7
ACIP
7
Alien Tort Statute
7
Anticompetitive Agreements
7
AOL
7
Banks
7
Blackberry
7
Brazil
7
Comcast
7
Commercial General Liability Policies
7
Compulsory Licenses
7
Conflicts of Interest
7
Contract Interpretation
7
Copyright Litigation
7
Copyright Office
7
Countervailing Duties
7
Criminal Prosecution
7
Databases
7
DDR Holdings v Hotels.com
7
Declaratory Relief
7
Drug Pricing
7
Economic Espionage Act
7
Effective Filing Date
7
Email
7
Energy
7
Enhanced Penalties
7
Fair Market Value
7
Federal Rules of Evidence
7
Fiduciary Duty
7
Final Action
7
Financial Products
7
Food Labeling
7
Foreign Sales
7
Genzyme
7
Grace Period
7
Health Care Providers
7
Health Insurance
7
India
7
Inherent Disclosure Doctrine
7
Intellectual Property Owners Association
7
International Harmonization
7
Internet Service Providers (ISPs)
7
Limitation Periods
7
Local Rules
7
Mandamus Petitions
7
MOFCOM
7
NAFTA
7
NIH
7
Nike
7
Obama Administration
7
Objective Unreasonableness Standard
7
Online Gaming
7
PLTIA
7
Product Labels
7
Putative Class Actions
7
Raising The Bar Act
7
Ratification
7
Reasonable Certainty Standard
7
Rebuttable Presumptions
7
Securities
7
Securities Fraud
7
Sony
7
Subject Matter Experts
7
Supplemental Information
7
Supply Contracts
7
Target
7
Tariffs
7
Technology Transfer Agreements
7
Tesla
7
The Clayton Act
7
Treatment Method Patents
7
U.S. Commerce Department
7
Unjust Enrichment
7
USDA
7
Warner Chilcott
7
WildTangent v Ultramercial
7
YouTube
6
Agency Deference
6
AIPLA
6
Airlines
6
Analogous Art
6
Article 50 Treaty of the EU
6
Audits
6
Bankruptcy Code
6
BEPS
6
Best Practices
6
Bifurcation
6
Big Data
6
Biofuel
6
Biogen Idec
6
Canadian Intellectual Property Office
6
CETA
6
Claim Amendments
6
Clear and Convincing Evidence
6
Collaboration
6
Competition Authorities
6
Computer Fraud and Abuse Act (CFAA)
6
Consent Order
6
Contempt
6
Coopertive Patent Classification System
6
Court of Federal Claims
6
Deadlines
6
Digital Media
6
Dismissal With Prejudice
6
eBay Test
6
Encryption
6
Entertainment Industry
6
Equitable Relief
6
Evidentiary Rulings
6
Federal Question Jurisdiction
6
Forum
6
Forward Publishing
6
FTAIA
6
GAO
6
Grable Factors
6
Graphical User Interface
6
Hearsay
6
Hiring & Firing
6
HTC America
6
Hulu
6
Information Reports
6
Insider Trading
6
Interference Claims
6
Internet Streaming
6
IPEC
6
Jazz Pharmaceuticals
6
Joint Inventors
6
Judge Rakoff
6
Judges
6
Jury Instructions
6
Kraft
6
Labeling
6
Legal History
6
Local Patent Rules
6
Memorandum of Guidance
6
Multidistrict Litigation
6
Multinationals
6
Music Industry
6
New Regulations
6
Nexium
6
NLRB
6
Noerr-Pennington Doctrine
6
Otsuka Pharmaceutical
6
Paris Convention
6
Priority Date Cutoff
6
Privacy Laws
6
Redskins
6
Renewable Energy
6
Resales Agreements
6
Reverse Payments
6
Right to a Jury
6
Roslin
6
Rule 26
6
Rules of Civil Procedure
6
Rules of Practice
6
Russia
6
Scienter
6
Section 102
6
Separation of Powers
6
Seventh Amendment
6
Shire Development v Watson
6
South Korea
6
Spoliation
6
Star Athletica v Varsity Brands
6
Strategic Planning
6
Supreme Court of Canada
6
Tax Rates
6
Telemedicine
6
TFEU
6
Third-Party Relationships
6
Trade Relations
6
Trials
6
Whistleblower Protection Policies
6
Wireless Devices
5
Administrative Appeals
5
Administrative Authority
5
Admissible Evidence
5
Antitrust Injuries
5
Arbitration Awards
5
Artificial Intelligence
5
AT&T
5
Banking Sector
5
Bitcoin
5
Board of Directors
5
Boilerplate Language
5
Broadcasting
5
Canon
5
Carnegie Mellon
5
Cheerleaders
5
Class Certification
5
Coca Cola
5
Common-Interest Privilege
5
Competition Act
5
Confidential Documents
5
Contract Disputes
5
COPPA
5
Cox Communications
5
Creditors
5
Data Privacy
5
Deceptive Intent
5
Defamation
5
Designs Act
5
Digital Goods
5
Disclaimers
5
Duty to Defend
5
Educational Institutions
5
EEA
5
Elan Pharmaceuticals
5
Elon Musk
5
Emerging Growth Companies
5
End-Users
5
European Union Intellectual Property Office (EUIPO)
5
Exclusivity
5
Exelixis
5
Exhaustion Doctrine
5
Expedited Actions Process
5
False Statements
5
Film Industry
5
Fitbit
5
Fracking
5
Gaming
5
Garmin Factors
5
Genuine Issue of Material Fact
5
Graham Factors
5
Honda
5
Honeywell International
5
Hotels.com
5
ICANN
5
Inducement
5
Information Technology
5
Insurance Industry
5
International Labor Laws
5
International Searching Authority
5
Internet of Things
5
IRS
5
Japan Patent Office
5
Keurig Inc
5
Korea
5
Law Matters
5
Leave to Amend
5
Legal Costs
5
Malicious Prosecution
5
March-in
5
McRo v Bandai Namco
5
Motion To Reconsider
5
Motion to Terminate
5
Motion to Vacate
5
National Cancer Moonshot
5
Nunc Pro Tunc
5
Online Videos
5
Opt-Outs
5
Parent Corporation
5
Patent Term Extensions
5
Patent-Misuse
5
Penalties
5
Phillips Standard
5
Precedential Opinion
5
Prioritized Examination
5
Proctor & Gamble
5
Professional Conferences
5
Quanta
5
RanBaxy
5
Reputational Injury
5
Restrictive Covenants
5
Retail Market
5
Risk Assessment
5
Scams
5
Scientific Research
5
Service of Process
5
Shareholder Litigation
5
Social Networks
5
Solar Energy
5
Sonos
5
Source Code
5
Sports
5
Standard Setting Organizations
5
State Law Claims
5
Strategic Enforcement Plan
5
Sunrise Periods
5
Tax Incentives
5
Tax Reform
5
TD Ameritrade
5
Time Extensions
5
TROL Act
5
TSA
5
Unified Patent System
5
Use in Commerce
5
Waivers
5
Whistleblowers
5
White Collar Crimes
5
Work-For-Hire
4
23andMe
4
3-D Technology
4
Adidas
4
Administrative Patent Judges
4
Advertising Injury
4
Affidavits
4
Africa
4
Amended Regulation
4
Annual Reports